Actively Recruiting
Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.
Led by M.D. Anderson Cancer Center · Updated on 2026-04-30
10
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
S
Saluda Medical Pty Ltd
Collaborating Sponsor
AI-Summary
What this Trial Is About
To explore the benefits of using closed loop spinal cord stimulation (SCS) in the treatment of patients experiencing painful chemotherapy induced peripheral neuropathy (CIPN) by assessing changes in pain, quality of life, pain medication use, sensory improvement through quantitative sensory testing, and improvement of gait through quantitative gait testing.
CONDITIONS
Official Title
Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 618 years
- Diagnosis history of chemotherapy induced peripheral neuropathy of lower extremities
- Patients with a prior or concurrent malignancy whose natural history or treatment does not interfere with safety or efficacy assessment of SCS
- Ability to understand and willingness to sign a written informed consent document
You will not qualify if you...
- Patients undergoing active chemotherapy or immunotherapy
- Patients undergoing medical litigation
- Patients with active infection being treated with antibiotics
- Patients who are pregnant or planning to conceive
- Patients receiving any investigational agents
- Patients with brain metastases
- Patients with cognitive impairment, psychiatric illness, or social situations limiting compliance with study requirements
- Patients with history of other sensorimotor neuropathies before CIPN
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
M
Matthew Chung, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here